Dealing with hair loss or thinning?

Chat with our Care Team

Start now

Understanding 5-Alpha Reductase Inhibitors

Kristin Hall, FNP

Reviewed by Kristin Hall, FNP

Written by Rachel Sacks

Updated 08/21/2022

Dealing with hair loss can be unavoidable for many men. Whether your hairline is only starting to recede or thinning all over, hair loss isn’t very enjoyable. You don’t have to sit back and watch your hair disappear, though. Today, there are many ways to protect your hairline, from medications to procedures like hair transplantation. One group of medications that treat hair loss is known as 5 alpha reductase inhibitors (5ARIs).

These drugs are present in several men’s health medications so we’ve covered everything you’d want to know about 5-alpha reductase inhibitors.

From how these drugs work and common side effects to potentially harmful interactions, keep reading for a comprehensive guide to 5 alpha reductase inhibitors.

5-alpha reductase inhibitors are a group of drugs used in the treatment of male pattern hair loss, or androgenetic alopecia.

These medications are also used for the management and treatment of an enlarged prostate gland (benign prostatic hyperplasia).

Drugs in this class include finasteride (sold under the brand names Proscar® and Propecia®) and dutasteride (marketed as Avodart®).

These drugs first became available in 1992, after finasteride’s approval by the Food and Drugs Administration (FDA).

Among hair loss and enlarged prostate glands, alpha reductase inhibitors may also be used to treat:

  • Hyperandrogenism (excessive presence of testosterone)

  • Hirsutism (excessive, abnormal growth of hair, typically in women)

  • Hormonal treatment in transgender women

Buy finasteride

more hair... there's a pill for that

Alpha reductase inhibitors work to reduce hair loss and thinning as well as treat enlarged prostate glands.

5-alpha reductase inhibitors work by blocking 5-alpha reductase, an enzyme that promotes the conversion of testosterone into dihydrotestosterone (DHT).

Testosterone converts into DHT in tissue such as the skin, liver, prostate and hair follicles.

While testosterone and DHT are both male sex hormones that bind to androgen receptors throughout the body, they have different effects.

Testosterone is responsible for growth during puberty and increased muscle mass in men.

DHT, on the other hand, is linked to male sex characteristics during prenatal development, prostate growth and hair patterns, including male pattern baldness.

For those genetically predisposed to male pattern baldness, DHT binds to androgen receptors in the scalp and causes hair follicles to stop producing new hairs gradually.

Our guide to DHT and male pattern baldness goes into more detail on this process and the effects of DHT on hair loss.

DHT is also responsible for prostate growth. An enlarged prostate is a common problem that affects up to 50 percent of men by the age of 60 and increases with age.

In someone with benign prostate hyperplasia (BPH), DHT can build up in the prostate gland and bind to prostatic androgen receptors, leading to enlargement of the prostate.

5-alpha reductase inhibitors block the enzyme responsible for testosterone converting to DHT, causing a decreased prostate size.

Will you join thousands of happy customers?

4.5 average rating

Before/after images shared by customers who have purchased varying products, including prescription based products. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. These customers’ results have not been independently verified. Individual results will vary. Customers were given free product.

There are currently two FDA-approved uses for 5-alpha-reductase inhibitors: managing hair loss and BPH.

Some healthcare providers may use alpha reductase inhibitors “off-label” for the treatment of hirsutism, a condition of excessive hair growth, typically in women.

The two FDA-approved 5-alpha reductase inhibitor drugs are finasteride and dutasteride.

Finasteride (Propecia® and Proscar®)

Finasteride is marketed under two different brand names: Propecia® and Proscar®.

Finasteride was originally developed in the 1970s and approved by the FDA in 1992 as a treatment for benign prostatic hyperplasia as Proscar®.

Finasteride was approved in 1997 as a treatment for hair loss in men under the brand name Propecia®.

Both drugs are used to treat BPH and its symptoms, such as frequent and difficult urination. It can also decrease the possibility of future prostate surgery.

Finasteride is also used to treat male pattern hair loss, gradual thinning of the hair on the scalp, a receding hairline or balding.

Depending on the condition being treated, finasteride is prescribed in different dosages as a daily oral tablet. 1mg of Propecia® is taken for hair loss treatment while 5mg of Proscar® is taken for BPH.

Dutasteride (Avodart®)

Dutasteride was patented in 1996 and received FDA approval in 2001 under the brand name Avodart®.

These drugs help manage symptoms of benign prostatic hyperplasia, which can include frequent urination, difficulty urinating or pain during urination.

Although some research shows that dutasteride is effective at treating hair loss, it is only approved by the FDA to treat BPH.

The effectiveness of dutasteride compared to finasteride is explored in more detail in our guide comparing the two medications.

Dutasteride comes as a 0.5mg oral capsule taken once a day.

Dutasteride is sometimes prescribed as a combination pill known as Jalyn® that also includes tamsulosin. Tamsulosin — also known by its brand name Flomax® — is an alpha-blocker medication that helps relax the muscles of the prostate and opening of the bladder to help improve the symptoms of BPH.

Like any medication, 5-alpha reductase inhibitors do come with the potential for side effects.

Both finasteride and dutasteride have similar possible side effects including:

Jalyn® has been reported to cause orthostatic hypotension, or low blood pressure, that occurs when standing up from a lying or sitting position, dizziness and weakness.

Alpha reductase inhibitors do come with potential risks and harmful interactions.

The use of 5-alpha reductase inhibitors can lead to an increased risk of high-grade prostate cancer.

Some men may experience an increase or decrease in prostate-specific antigen (PSA) levels while taking a 5-alpha reductase inhibitor. An increase in PSA levels while on treatment with a 5-alpha reductase inhibitor may indicate the presence of prostate cancer.

PSA levels should be measured before starting the use of alpha reductase inhibitors and monitored throughout treatment to evaluate the effects of the drug.

Finasteride may interact with St. John's Wort, an herbal supplement used for depression, anxiety, attention-deficit hyperactivity disorder and other conditions.

If you notice any of these side effects or symptoms of a drug interaction, contact your health provider immediately.

Hair loss treatments, delivered

While hair loss may be a common problem for many men, treatment is possible. One example of a common hair loss treatment is 5 alpha reductase inhibitors.

Two examples of alpha reductase inhibitors are finasteride and dutasteride. Both work by inhibiting the 5-alpha reductase enzyme and stopping your body from converting testosterone into dihydrotestosterone, or DHT. 

By reducing DHT levels, both medications are shown to slow down, stop or reverse the effects of male pattern baldness.

This class of drugs can also treat an enlarged prostate and help manage the symptoms of benign prostatic hyperplasia.

If you’re concerned about hair loss or an enlarged prostate, it’s important to talk to a healthcare provider about possible treatment plans.

16 Sources

Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references.

  1. 5-Alpha Reductase Inhibitor Information FDA. (2016, October 14). US Food and Drug Administration. Retrieved from
  2. Salisbury, B. H., & Tadi, P. (2022, April 7). 5 Alpha Reductase Inhibitors - StatPearls. NCBI. Retrieved from
  3. Zito, P. M., Bistas, K. G., & Syed, K. (2022, May 8). Finasteride - StatPearls. NCBI. Retrieved from
  4. Randall V. A. (1994). Role of 5 alpha-reductase in health and disease. Bailliere's clinical endocrinology and metabolism, 8(2), 405–431. Retrieved from
  5. Kinter, K. J., & Anekar, A. A. (2022, March 9). Biochemistry, Dihydrotestosterone - StatPearls. NCBI. Retrieved from
  6. Roehrborn C. G. (2005). Benign prostatic hyperplasia: an overview. Reviews in urology, 7 Suppl 9(Suppl 9), S3–S14. Retrieved from
  7. Drug Approval Package: Propecia NDA# 020788. (2003, August 7). Retrieved from
  8. Finasteride. (n.d.). MedlinePlus. Retrieved from
    (n.d.). Retrieved from
  9. Benign Prostatic Hyperplasia (BPH): Symptoms & Treatments. (2020, March 10). Cleveland Clinic. Retrieved from
  10. Shanshanwal, S. J., & Dhurat, R. S. (2017). Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Indian journal of dermatology, venereology and leprology, 83(1), 47–54. Retrieved from
  11. Jalyn (dutasteride and tamsulosin hydrochloride) capsules label. (n.d.). Retrieved from
  12. Tamsulosin. (2018, January 15). MedlinePlus. Retrieved from
  13. Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. The Journal of clinical and aesthetic dermatology, 9(7), 56–62. Retrieved from
  14. 5-alpha reductase inhibitors increase the risk of prostate cancer. (2018, February 8). US Food and Drug Administration. Retrieved from
  15. St. John's Wort NCCIH. (n.d.). National Center for Complementary and Integrative Health. Retrieved from
Editorial Standards

Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!

This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.

Kristin Hall, FNP

Kristin Hall is a board-certified Family Nurse Practitioner with decades of experience in clinical practice and leadership. 

She has an extensive background in Family Medicine as both a front-line healthcare provider and clinical leader through her work as a primary care provider, retail health clinician and as Principal Investigator with the NIH

Certified through the American Nurses Credentialing Center, she brings her expertise in Family Medicine into your home by helping people improve their health and actively participate in their own healthcare. 

Kristin is a St. Louis native and earned her master’s degree in Nursing from St. Louis University, and is also a member of the American Academy of Nurse Practitioners. You can find Kristin on LinkedIn for more information.

Read more